These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3010327)

  • 1. Effect of delta 9-tetrahydrocannabinol on herpes simplex virus type 2 vaginal infection in the guinea pig.
    Cabral GA; Mishkin EM; Marciano-Cabral F; Coleman P; Harris L; Munson AE
    Proc Soc Exp Biol Med; 1986 Jun; 182(2):181-6. PubMed ID: 3010327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. delta-9-Tetrahydrocannabinol decreases host resistance to herpes simplex virus type 2 vaginal infection in the B6C3F1 mouse.
    Mishkin EM; Cabral GA
    J Gen Virol; 1985 Dec; 66 ( Pt 12)():2539-49. PubMed ID: 2999306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delta 9-tetrahydrocannabinol decreases alpha/beta interferon response to herpes simplex virus type 2 in the B6C3F1 mouse.
    Cabral GA; Lockmuller JC; Mishkin EM
    Proc Soc Exp Biol Med; 1986 Feb; 181(2):305-11. PubMed ID: 3003756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical SMIP-7.7, a toll-like receptor 7 agonist, protects against genital herpes simplex virus type-2 disease in the guinea pig model of genital herpes.
    Bernstein DI; Cardin RD; Bravo FJ; Earwood J; Clark JR; Li Y; Mishra P; Li C; Nayak BP; Miller AT; Wu TY; Cooke MP; Valiante NM
    Antivir Chem Chemother; 2014 Apr; 23(5):189-96. PubMed ID: 23232327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Herpes simplex virus genital infection of the female guinea pig as a model for the evaluation of an experimental vaccine.
    Thornton B; Baskerville A; Bailey NE; Melling JM; Hambleton P
    Vaccine; 1984 Jun; 2(2):141-8. PubMed ID: 6099646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrent genital herpes simplex virus infection in guinea pigs.
    Stanberry LR; Kern ER; Richards JT; Overall JC
    Intervirology; 1985; 24(4):226-31. PubMed ID: 3000982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of herpes simplex virus type 2 (HSV-2) -specific cell-mediated immune responses in guinea pigs during latent HSV-2 genital infection.
    Perry CL; Banasik BN; Gorder SR; Xia J; Auclair S; Bourne N; Milligan GN
    J Immunol Methods; 2016 Dec; 439():1-7. PubMed ID: 27659010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of primary herpes simplex virus infection in guinea pigs by imiquimod.
    Miller RL; Imbertson LM; Reiter MJ; Gerster JF
    Antiviral Res; 1999 Nov; 44(1):31-42. PubMed ID: 10588331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of herpes simplex virus vaccines in animals: the guinea pig vaginal model.
    Stanberry LR
    Rev Infect Dis; 1991; 13 Suppl 11():S920-3. PubMed ID: 1664129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in the vaginal cytology of the guinea pig induced by herpes simplex virus.
    Lucia HL; Mayo DR; Hsiung GD
    Acta Cytol; 1983; 27(3):365-70. PubMed ID: 6223477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zosteriform spread of herpes simplex virus type 2 genital infection in the guinea-pig.
    Bernstein DI; Stanberry LR
    J Gen Virol; 1986 Sep; 67 ( Pt 9)():1851-7. PubMed ID: 3018127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genital herpes: pathogenesis and chemotherapy in the guinea pig model.
    Hsiung GD; Mayo DR; Lucia HL; Landry ML
    Rev Infect Dis; 1984; 6(1):33-50. PubMed ID: 6324317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genital reinfection after recovery from initial genital infection with herpes simplex virus type 2 in guinea pigs.
    Stanberry LR; Bernstein DI; Kit S; Myers MG
    J Infect Dis; 1986 Jun; 153(6):1055-61. PubMed ID: 3009643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The HSV-1 live attenuated VC2 vaccine provides protection against HSV-2 genital infection in the guinea pig model of genital herpes.
    Bernstein DI; Pullum DA; Cardin RD; Bravo FJ; Dixon DA; Kousoulas KG
    Vaccine; 2019 Jan; 37(1):61-68. PubMed ID: 30471955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody response to the herpes simplex virus type 2 AG-4 antigen in guinea pigs with genital herpes infections.
    Maragos C; Miller A; May JT
    Aust J Exp Biol Med Sci; 1986 Feb; 64 ( Pt 1)():89-95. PubMed ID: 3008691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of DNA immunization formulated with bupivacaine in murine and guinea pig models of genital herpes simplex virus infection.
    Bernstein DI; Tepe ER; Mester JC; Arnold RL; Stanberry LR; Higgins T
    Vaccine; 1999 Apr; 17(15-16):1964-9. PubMed ID: 10217595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of acyclovir on genital infection with herpes simplex virus types 1 and 2 in the guinea pig.
    Landry ML; Lucia HL; Hsiung GD; Pronovost AD; Dann PR; August MJ; Mayo DR
    Am J Med; 1982 Jul; 73(1A):143-50. PubMed ID: 6285705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a novel, anti-herpes simplex virus compound, acyclovir elaidate (P-4010), in the female guinea pig model of genital herpes.
    Jennings R; Smith TL; Myhren F; Phillips J; Sandvold ML
    Antimicrob Agents Chemother; 1999 Jan; 43(1):53-61. PubMed ID: 9869565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of shRNA-containing herpes simplex virus type 1 (HSV-1)-based gene therapy for HSV-2-induced genital herpes.
    Liu Z; Xiang Y; Wei Z; Yu B; Shao Y; Zhang J; Yang H; Li M; Guan M; Wan J; Zhang W
    J Virol Methods; 2013 Nov; 193(2):353-8. PubMed ID: 23845900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity, protective efficacy, and non-replicative status of the HSV-2 vaccine candidate HSV529 in mice and guinea pigs.
    Bernard MC; Barban V; Pradezynski F; de Montfort A; Ryall R; Caillet C; Londono-Hayes P
    PLoS One; 2015; 10(4):e0121518. PubMed ID: 25837802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.